Skip to main content
FinSpry Logo
FinSpry
CGON logo
CGON
(NASDAQ)
CG Oncology, Inc.
$64.76-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

CG Oncology (CGON) Stock Price & Financial Analysis

CG Oncology Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$63.51 - $65.97
52-Week High$73.56
52-Week Low$23.32
Open$64.17
Volume767.70K
Average Volume (3M)1.03M
Market Cap4.86B
Shares Outstanding77.30M
Price to Sales (P/S)1280.67
Price to Book (P/B)6.87
EV/EBITDA-27.18
Revenue (TTM)4.04M
Net Income (TTM)-161.00M
Free Cash Flow (TTM)-132.48M
EPS (TTM)$-2.10
Profit Margin-3985.02%
Operating Margin-4722.13%
Return on Equity (ROE)-21.39%
Debt to Equity0.01
50-Day MA$66.62
200-Day MA$47.36
52-Week Change175.52%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About CG Oncology

What is the current stock price for CGON?

As of the latest trading session, CGON stock trades at $64.76. The 52-week range is $23.32–$73.56, with a day range of $63.51–$65.97.

What is the P/E ratio for CGON?

The P/E ratio (Price-to-Earnings) for CGON is shown in the Key Statistics section. This valuation metric helps compare CG Oncology, Inc. to industry peers.

Does CGON pay dividends?

CG Oncology does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CGON?

Based on 9 analysts, the consensus for CGON is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of CGON?

CG Oncology's market capitalization is $5.01B, classifying it as a mid-cap company. CG Oncology operates in the Healthcare sector within the Biotechnology industry.